What is Red Queen Bio?
Red Queen Bio is at the forefront of biosecurity innovation, leveraging advanced AI models, automated laboratory processes, and scalable countermeasure development to proactively defend against rapidly emerging biological risks. The company's core mission involves mapping potential biothreats and architecting swift, effective responses. By collaborating with research institutions and governmental bodies, Red Queen Bio aims to bolster global safety protocols and enhance resilience against biological hazards.
How much funding has Red Queen Bio raised?
Red Queen Bio has raised a total of $15M across 1 funding round:
Seed
$15M
Seed (2025): $15M with participation from Halcyon Futures, Fifty Years, Cerberus, and OpenAI
Key Investors in Red Queen Bio
Halcyon Futures
Halcyon Futures is a venture capital firm focused on supporting ambitious leaders in launching impactful projects, providing seed funding and operational support. They specialize in transformative artificial intelligence and have a track record of incubating organizations and securing significant funding for their ventures.
Fifty Years
Fifty Years is a pre-seed and seed-stage venture capital firm that backs founders using technology to solve major global challenges like disease and climate change. They are instrumental in helping scientists and engineers transition into entrepreneurship and have a strong network within the deep tech startup ecosystem.
Cerberus
Cerberus Capital Management is a global alternative investment firm with expertise in private equity and distressed investments. They focus on operational improvements and long-term value creation across various industries and market cycles.
What's next for Red Queen Bio?
This substantial Seed financing positions Red Queen Bio for accelerated growth and expanded operational capabilities. The strategic investment signals strong market confidence in the company's unique approach to biosecurity. Future endeavors will likely focus on scaling its AI-driven threat detection platforms, further automating countermeasure design, and forging deeper partnerships to fortify global health infrastructure against an increasingly complex threat landscape. The company's trajectory suggests a move towards broader implementation and potentially larger-scale enterprise solutions.
See full Red Queen Bio company page
